Commission Regulation (EC) No 1356/2005 of 18 August 2005 amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards oxolinic acid and morantel   (Text with EEA relevance)
Date: 2005-08-18
Institutions: European Commission
Subjects: European standard, animal product, food safety, foodstuff, foodstuffs legislation, health policy, veterinary drug

19.8.2005

EN

Official Journal of the European Union

L 214/3

COMMISSION REGULATION (EC) No 1356/2005

of 18 August 2005

amending Annex I to Council Regulation (EEC) No 2377/90 laying down a Community procedure
for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of
animal origin, as regards oxolinic acid and morantel

(Text with EEA relevance)

THE COMMISSION OF THE EUROPEAN COMMUNITIES,

and for porcine and poultry species
the maximum
residue limit concerning fat relates to ‘skin and fat in
natural proportions’.

Having regard to the Treaty
Community,

establishing the European

Having regard to Council Regulation (EEC) No 2377/90 of 26
June 1990 laying down a Community procedure for the estab-
lishment of maximum residue limits of veterinary medicinal
products in foodstuffs of animal origin (1), and in particular
Article 2 thereof,

(3)

Morantel has been included in Annex I to Regulation
(EEC) No 2377/90 for bovine and ovine for muscle,
fat,
liver, kidney and milk. That entry should be
extended to all ruminants.

(4)

Regulation (EEC) No 2377/90 should be amended
accordingly.

Having regard to the opinion of
the European Medicines
Agency formulated by the Committee for Medicinal Products
for Veterinary Use,

(5)

Whereas:

An adequate period should be allowed before the applic-
ability of this Regulation in order to enable Member
States to make any adjustment which may be necessary
in the light of this Regulation to the marketing author-
accordance with Directive
isations
2001/82/EC of
the
Council of 6 November 2001 on the Community code
relating to veterinary medicinal products (2).

the European Parliament and of

granted

in

(1)

(2)

All pharmacologically active substances which are used
within the Community in veterinary medicinal products
intended for administration to food-producing animals
should be evaluated in accordance with Regulation
(EEC) No 2377/90.

(6)

The measures provided for in this Regulation are in
Standing
the
the
accordance with
Committee on Veterinary Medicinal Products,

opinion

of

Oxolinic acid has been included in Annex I to Regulation
(EEC) No 2377/90 for chicken and porcine for muscle,
liver and kidney, for muscle and skin in
skin and fat,
natural proportions for fin fish and excluding animals
from which eggs are produced for human consumption.
The entry should be extended to all
food-producing
species excluding animals from which milk or eggs are
produced for human consumption, for fin fish, this entry
relates only to ‘muscle and skin in natural proportions’

HAS ADOPTED THIS REGULATION:

Article 1

Annex I
accordance with the Annex to this Regulation.

to Regulation (EEC) No 2377/90 is amended in

(1) OJ L 224, 18.8.1990, p. 1. Regulation as

last amended by
Commission Regulation (EC) No 1299/2005 (OJ L 206, 9.8.2005,
p. 4).

(2) OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive

2004/28/EC (OJ L 136, 30.4.2004, p. 58).

L 214/4

EN

Official Journal of the European Union

19.8.2005

This Regulation shall enter into force on the third day following its publication in the Official Journal of the
European Union.

Article 2

It shall apply from 18 October 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 18 August 2005.

For the Commission

Günter VERHEUGEN
Vicepresident

19.8.2005

EN

Official Journal of the European Union

L 214/5

s
e
u
s
s
i
t

t
e
g
r
a
T

)
2
(

e
l
c
s
u
M

)
3
(

t
a
F

r
e
v
i
L

y
e
n
d
K

i

g
k
/
g

μ
0
0
1

g
k
/
g

μ
0
5

g
k
/
g

μ
0
5
1

g
k
/
g

μ
0
5
1

s
L
R
M

s
e
u
s
s
i
t

t
e
g
r
a
T

e
l
c
s
u
M

r
e
v
i
L

t
a
F

y
e
n
d
K

i

k

l
i

M

g
k
/
g

μ
0
0
1

g
k
/
g

μ
0
0
1

g
k
/
g

μ
0
0
8

g
k
/
g

μ
0
0
2

g
k
/
g

μ
0
5

s
L
R
M

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

)
1
(

s
e
i
c
e
p
s

g
n
i
c
u
d
o
r
p
-
d
o
o
f

l
l

A

d
i
c
a

c
i
n

i
l

o
x
O

d
i
c
a

c
i
n

i
l

o
x
O

h
s
i
f

n
i
f

o
t

y
l
p
p
a

t
o
n

o
d

y
e
n
d
k

i

d
n
a

r
e
v
i
l

,
t
a
f

r
o
f

s
L
R
M

;

n
o
i
t
p
m
u
s
n
o
c

n
a
m
u
h

r
o
f

d
e
c
u
d
o
r
p

e
r
a

r
o

k

l
i

m

h
c
i
h
w

m
o
r
f

s
l
a
m
n
a

i

n

i

e
s
u

r
o
f

t
o
N

‘

n

i

o
t

s
g
g
e

i

n
k
s

.

’

s
n
o
i
t
r
o
p
o
r
p

l
a
r
u
t
a
n

n

i

t
a
f

d
n
a

i

n
k
s

s
e
t
a
l
e
r

L
R
M

s
i
h
t

s
e
i
c
e
p
s

y
r
t
l
u
o
p

d
n
a

e
n
i
c
r
o
p

;

’

s
n
o
i
t
r
o
p
o
r
p

l
a
r
u
t
a
n

‘

d
n
a

e
l
c
s
u
m

o
t

s
e
t
a
l
e
r

L
R
M

s
i
h
t

h
s
i
f

n
i
f

r
o
F

r
o
F

)
1
(

)
2
(

)
3
(

,

-
3
1
-
l
y
h
t
e
m
N

-

o
t

d
e
s
y
l
o
r
d
y
h

d
e
s
s
e
r
p
x
e

d
n
a

i

e
n
m
a
i
d
e
n
a
p
o
r
p

s
t
n
e
l
a
v
i
u
q
e

l
e
t
n
a
r
o
m

s
a

s
e
i
c
e
p
s

l
a
m
n
A

i

e
u
d
i
s
e
r

r
e
k
r
a
M

)
s
(
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
P

s
t
n
a
n
m
u
r

i

l
l

A

e
b

y
a
m

h
c
i
h
w

s
e
u
d
i
s
e
r

f
o

m
u
S

l
e
t
n
a
r
o
M

s
e
t
i
s
a
r
a
p
o
d
n
e

t
s
n
i
a
g
a

g
n
i
t
c
a

s
t
n
e
g
A

s
e
d
m

i

i
r
y
p
o
r
d
y
h
a
r
t
e
T

.

.

1
2

.

.

7
1
2

.

s
t
n
e
g
a

c
i
t
i
s
a
r
a
p
i
t
n
A

.

2

X
E
N
N
A

)
d
e
x
i
f

n
e
e
b

e
v
a
h

s
t
i

m

i
l

e
u
d
i
s
e
r

m
u
m
i
x
a
m

h
c
i
h
w

r
o
f

s
e
c
n
a
t
s
b
u
s

e
v
i
t
c
a

l

y
l
l
a
c
i
g
o
o
c
a
m
r
a
h
p

f
o

t
s
i
L
(

I

x
e
n
n
A

n

i

d
e
t
r
e
s
n

i

e
r
a

s
e
c
n
a
t
s
b
u
s

i

g
n
w
o

l
l

o
f

e
h
T

s
t
n
e
g
a

s
u
o
i
t
c
e
f
n
i
-
i
t
n
A

i

s
c
i
t
o
b
i
t
n
A

l

s
e
n
o
o
n
u
Q

i

.

.

A

.

1

.

2
1

.

.

3
2
1

.